Interactions between short and long noncoding RNAs

FEBS Letters
Igor Ulitsky

Abstract

It is now evident that noncoding RNAs play key roles in regulatory networks determining cell fate and behavior, in a myriad of different conditions, and across all species. Among these noncoding RNAs are short RNAs, such as MicroRNAs, snoRNAs, and Piwi-interacting RNAs, and the functions of those are relatively well understood. Other noncoding RNAs are longer, and their modes of action and functions are also increasingly explored and deciphered. Short RNAs and long noncoding RNAs (lncRNAs) interact with each other with reciprocal consequences for their fates and functions. LncRNAs serve as precursors for many types of small RNAs and, therefore, the pathways for small RNA biogenesis can impinge upon the fate of lncRNAs. In addition, lncRNA expression can be repressed by small RNAs, and lncRNAs can affect small RNA activity and abundance through competition for binding or by triggering small RNA degradation. Here, I review the known types of interactions between small and long RNAs, discuss their outcomes, and bring representative examples from studies in mammals.

References

Dec 6, 2002·Nature·Y OkazakiUNKNOWN RIKEN Genome Exploration Research Group Phase I & II Team
Jan 24, 2007·RNA·Xuezhong Cai, Bryan R Cullen
Mar 14, 2007·Annual Review of Biochemistry·Yao-Fu ChangMiles F Wilkinson
May 19, 2007·Science·Philipp KapranovThomas R Gingeras
Jul 24, 2007·Nature Genetics·José Manuel Franco-ZorrillaJavier Paz-Ares
Aug 19, 2007·Nature Methods·Margaret S EbertPhillip A Sharp
Nov 6, 2007·Trends in Genetics : TIG·Giorgio DieciAldo Pagano
Jun 19, 2010·Science·Stefan L AmeresPhillip D Zamore
Jun 19, 2010·Science·Demián CazallaJoan A Steitz
Sep 28, 2010·Bioinformatics·Nenad Bartonicek, Anton J Enright
Oct 13, 2010·Current Biology : CB·Margaret S Ebert, Phillip A Sharp
Nov 18, 2010·Molecular Systems Biology·Erik LarssonDebora Marks
May 10, 2011·Trends in Cell Biology·Orly Wapinski, Howard Y Chang
Aug 2, 2011·Cell·Leonardo SalmenaPier Paolo Pandolfi
Dec 21, 2011·Proceedings of the National Academy of Sciences of the United States of America·Valentina LibriAmy H Buck
Jun 23, 2012·Nature·Dimitrios G ZisoulisAmy E Pasquinelli
Sep 11, 2012·Molecular Cell·Qing-Fei YinLing-Ling Chen
Oct 18, 2012·Genes & Development·Jeremy E WiluszPhillip A Sharp
Nov 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jessica A BrownJoan A Steitz
Mar 1, 2013·Nature·Thomas B HansenJørgen Kjems
Mar 1, 2013·Nature·Sebastian MemczakNikolaus Rajewsky
Mar 12, 2013·Biophysical Journal·Matteo FigliuzziAndrea De Martino
Jun 26, 2013·Cell Reports·Magali SoumillonHenrik Kaessmann
Jun 25, 2013·Cancer Letters·Xuefei ShiYong Song
Jun 26, 2013·Nature Reviews. Genetics·Maartje J Luteijn, René F Ketting
Jul 6, 2013·Cell·Igor Ulitsky, David P Bartel
Jan 17, 2014·Nature·Yvonne TayPier Paolo Pandolfi

❮ Previous
Next ❯

Citations

Jan 12, 2019·Human Gene Therapy. Clinical Development·Liang HanXudong Wu
Feb 6, 2020·Inflammatory Bowel Diseases·Petr JabandzievAjay Goel
Feb 25, 2020·The EMBO Journal·Ruth L SealElspeth A Bruford
Apr 25, 2020·FEBS Letters·Nimrod Madrer, Hermona Soreq
Jan 5, 2020·Cold Spring Harbor Symposia on Quantitative Biology·Hadas HezroniIgor Ulitsky
Feb 9, 2020·International Journal of Molecular Sciences·Marek KazimierczykJan Wrzesinski
Aug 14, 2020·Genes·Ganesan Arunkumar, Daniël P Melters
Aug 1, 2020·Frontiers in Cell and Developmental Biology·Anny W RobertPatrícia Shigunov
Sep 11, 2018·FEBS Letters·Mihaela Zavolan, André P Gerber
Feb 6, 2020·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Xiaoying Jiang, Qilan Ning
Jul 14, 2020·Frontiers in Cellular and Infection Microbiology·Muxing LiuPing Wang
Mar 12, 2019·Therapeutic Advances in Medical Oncology·Gloria RavegniniSabrina Angelini
Jun 15, 2019·Archives of Gynecology and Obstetrics·Meiqin YangYue Wang
Sep 23, 2020·Menopause : the Journal of the North American Menopause Society·Lihui SiYan Jia
Mar 1, 2020·Experimental and Molecular Pathology·Soudeh Ghafouri-FardMohammad Taheri
Dec 10, 2020·JHEP Reports : Innovation in Hepatology·Amin Mahpour, Alan C Mullen
Dec 19, 2020·Open Medicine·Yawei FengFurong Song
Apr 17, 2020·Mechanisms of Ageing and Development·Xiaoying Jiang, Qilan Ning
Oct 29, 2020·Menopause : the Journal of the North American Menopause Society·Lihui SiYan Jia
May 6, 2021·International Journal of Molecular Sciences·Mariana LopesRaquel Chaves
May 12, 2021·Disease Models & Mechanisms·Meredith Hill, Nham Tran
Jul 3, 2021·Non-coding RNA·Melcy PhilipSonika Tyagi
Apr 14, 2019·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Songyang LiuYahui Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Related Papers

Cellular and Molecular Life Sciences : CMLS
Soichiro YamamuraRajvir Dahiya
Genomics, Proteomics & Bioinformatics
Farooq RashidGe Shan
© 2022 Meta ULC. All rights reserved